Joint Pain Clinical Trial
Official title:
Prevalence of Muscle, Joint and Nerve Pain in Spinal Disorders.
The purpose of the study is to provide adequate information about the percentage of the main tissue that causing pain in most common spinal disorders either it is muscular, nerve or joint in each spinal parts, that will provide the physical therapist with large data that can be helpful in differential diagnosis.
Status | Recruiting |
Enrollment | 300 |
Est. completion date | July 2024 |
Est. primary completion date | May 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility | Inclusion Criteria: 1. - patients from 18 to 60years 2. - both gender and any condition diagnosed by orthopedic physician with spinal disorders 3. - pre and post operative patient may be included. Exclusion Criteria: 1. viscerogenic pain 2. cancer 3. psychogenic pain or psychogenic disorder 4. rheumatoid arthritis 5. fibromyalgia. |
Country | Name | City | State |
---|---|---|---|
Egypt | Faculty of Physical Therapy Cairo University | Giza |
Lead Sponsor | Collaborator |
---|---|
Hadeer Gomaa Ebraheem Aly |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | muscle pain | muscle pain with pressure algometer ,stretch and resisted range of motion . | 5 months | |
Primary | joint pain | joint pain with joint play and physiological range of motion . | 5 months | |
Primary | nerve pain | nerve pain with tinel sign and neural tension test . | 5 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05052112 -
Cross-Over Study to Evaluate the Efficacy of E-PR-01 on Activity Induced Joint Pain
|
N/A | |
Recruiting |
NCT04285112 -
SPRINT: Signature for Pain Recovery IN Teens
|
||
Completed |
NCT04506411 -
Turmeric Efficacy for Mobility and Joint Function
|
N/A | |
Terminated |
NCT00973141 -
A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain
|
Phase 2 | |
Completed |
NCT04408560 -
Evaluation of the Efficacy of a Homeopathic Protocol in Patients With Non-metastatic Breast Cancer
|
N/A | |
Completed |
NCT04150211 -
Effects of Exten(d) Supplementation on Training Ability in Recreational Runners
|
Phase 2 | |
Completed |
NCT03209895 -
Study to Evaluate the Safety and Efficacy of a Proprietary "Joint Health" Dietary Supplement in Subjects With Joint and Connective Tissue Pain
|
N/A | |
Withdrawn |
NCT01612728 -
Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast Cancer
|
Phase 2 | |
Completed |
NCT00691678 -
Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer
|
Phase 2 | |
Recruiting |
NCT05212259 -
Clinical Study to Evaluate the Effect of Different Doses of UC-II® Supplementation on the Range of Motion & Joint Discomfort in Healthy Subjects
|
N/A | |
Recruiting |
NCT04182659 -
Long Term Efficacy of Neuronavigation Guided rTMS in Alleviating Gulf War Illness Related Headaches and Pain Symptoms
|
N/A | |
Terminated |
NCT04712019 -
Evaluating Edema and Range of Motion Using Negative Pressure Therapy vs. Standard Surgical Dressing in Bilateral TKA
|
N/A | |
Recruiting |
NCT06074744 -
Subsartorial Nerve Block and Femoral Nerve Block in Total Knee Arthroplasty
|
N/A | |
Recruiting |
NCT00325845 -
Synvisc Injections for Lumbar Facet Joint Pain
|
Phase 3 | |
Terminated |
NCT04872556 -
Evaluation of the Effect of Laser Acupuncture on Taxane Acute Pain Syndrome Patients
|
N/A | |
Active, not recruiting |
NCT03865992 -
Curcumin in Reducing Joint Pain in Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint Disease
|
N/A | |
Recruiting |
NCT05282992 -
NAtive Collagen Type II In Healthy VoluntEers With Joint Discomfort
|
N/A | |
Recruiting |
NCT04994249 -
Diagnostic and Prognostic Biomarkers for High-impact Chronic Pain: Development and Validation
|
||
Completed |
NCT01509079 -
Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors
|
Phase 2 | |
Completed |
NCT04764110 -
Short-term Impact of Cyplexinol® on Self-reported Joint Pain
|
N/A |